Overview
Dimethicone is a silicone oil that is also known as polydimethylsiloxane (PDMS). It has viscoelastic properties. Dimethicone is used as a surfactant, antifoaming agent, carminative in various products such as medical devices, food products, and lubricants. It is used in a number of health and beauty products including hair care products such as shampoo, conditioner, leave-in conditioner, and de-tangling products. On skin, it is also observed to have moisturizing actions . A study found that that the 100 % dimethicone product is a safe and highly effective head lice treatment for children and may serve as less toxic and less resistance-prone alternative to pesticide-containing products .
Indication
Dimethicone is a colorless liquid with both cosmetic and therapeutic uses. It is used in topical creams and ointments to help distribute the active ingredients. Dimethicone is used as an anti-foaming agent, a hair and skin conditioner, and in the treatment of head lice and, as an anti-bloating/anti-flatulence agent , .
Associated Conditions
- Acute Diarrhea
- Aerophagy
- Dry Skin
- Duodenal Ulcer
- Dyspepsia
- Flatulence
- Gastric Ulcer
- Gastritis
- Gastro-esophageal Reflux Disease (GERD)
- Hiatus Hernia
- Pancreatic Insufficiency
- Post Operative Gas
- Pre-operative Gas
- Stress Ulcers
Clinical Trials
Title | Posted | Study ID | Phase | Status | Sponsor |
---|---|---|---|---|---|
2024/12/09 | Phase 2 | Active, not recruiting | Healthgen Biotechnology Corp. | ||
2024/12/03 | Not Applicable | Recruiting | |||
2024/02/05 | Phase 4 | Recruiting | |||
2016/01/21 | Phase 3 | Completed | |||
2013/08/02 | Phase 2 | Completed | |||
2008/06/23 | Phase 2 | Completed |
FDA Drug Approvals
Approved Product | Manufacturer | NDC Code | Route | Strength | Effective Date |
---|---|---|---|---|---|
TARGET CORPORATION | 11673-066 | ORAL | 125 mg in 1 1 | 4/11/2025 | |
Jiangxi Hemei Pharmaceutical Co., Ltd | 84010-122 | TOPICAL | 2 g in 100 g | 5/25/2025 | |
The Mentholatum Company | 10742-8745 | TOPICAL | 20 mg in 1 g | 5/2/2025 | |
Amerisource Bergen | 46122-620 | ORAL | 125 mg in 1 1 | 4/8/2025 | |
Retail Business Services, LLC | 72476-619 | TOPICAL | 13 mg in 1 mL | 3/24/2025 | |
Little Pharma. Inc. | 72559-041 | ORAL | 180 mg in 180 mg | 7/6/2025 | |
PHARMAMED USA INC | 84289-408 | TOPICAL | 1.8 g in 100 g | 3/18/2025 | |
ATLANTIC BIOLOGICALS CORP | 17856-1141 | ORAL | 20 mg in 0.3 mL | 5/28/2025 | |
Renu Laboratories, LLC | 76348-580 | TOPICAL | 3.36 g in 168 g | 4/18/2025 | |
Geri-Care Pharmaceuticals, Corp | 57896-004 | ORAL | 20 mg in 5 mL | 3/31/2025 |
EMA Drug Approvals
Approved Product | Authorization Holder | Status | Issued Date |
---|---|---|---|
No EMA approvals found for this drug. |
HSA Drug Approvals
Approved Product | Manufacturer | Approval Number | Dosage Form | Strength | Approval Date |
---|---|---|---|---|---|
VERAGEL-DMS TABLET | SIN02547P | TABLET | 10 mg | 4/19/1989 | |
GASCOAL TABLET 50 mg | SIN07758P | TABLET | 50 mg | 7/1/1994 | |
MACGEL TABLET | SIN08119P | TABLET | 25 mg | 4/11/1995 | |
ENZYPLEX TABLET | SIN06211P | ENTERIC COATED TABLET | 25 mg | 5/3/1991 | |
GERSKIN TABLET | SIN07893P | TABLET | 20 mg | 10/31/1994 |
NMPA Drug Approvals
Approved Product | Company | Approval Number | Drug Type | Dosage Form | Approval Date |
---|---|---|---|---|---|
No NMPA approvals found for this drug. |
PPB Drug Approvals
Approved Product | Registration No. | Company | Licence No. | Strength | Registration Date |
---|---|---|---|---|---|
DIMETHICONE TAB 40MG (JEN SHENG) | N/A | N/A | N/A | 8/8/2001 |
TGA Drug Approvals
Approved Product | ARTG ID | Sponsor | Registration Type | Status | Registration Date |
---|---|---|---|---|---|
No TGA approvals found for this drug. |
Health Canada Drug Approvals
Approved Product | Company | DIN | Dosage Form | Strength | Market Date |
---|---|---|---|---|---|
SELAN + | span-america medical systems inc. | 02489643 | Cream - Topical | 2.1 % / W/W | N/A |
NUTRASHIELD | 02291614 | Cream - Topical | 1.0 % | 2/8/2010 | |
CLEAN N MOIST - ASP-LIQ 1.5% | hollister limited | 02144638 | Liquid
,
Spray - Topical | 1.5 % | 12/31/1955 |
PHAZYME LIQUID 40MG/0.6ML | reed & carnrick, division of block drug company (canada) ltd. | 01932276 | Liquid - Oral | 40 MG / .6 ML | 12/31/1993 |
CLEANSING BODY LOTION | 02291592 | Lotion - Topical | 1.5 % / W/W | 2/8/2010 | |
ANTACID LIQUID SUSP | shoppers drug mart inc. | 00417920 | Suspension - Oral | 25 MG / 5 ML | 12/31/1977 |
BABYS OWN TUMMY TAB | G.T. Fulford Pharmaceuticals | 00397083 | Tablet - Oral | 2 MG / TAB | 12/31/1977 |
BABY'S OWN INFANT DROPS - 40MG/0.6ML | block drug company (canada) ltd. | 02227606 | Drops - Oral | 40 MG / .6 ML | 1/17/1997 |
OVOL 160MG CHEWABLE TABLETS | carter-horner corp. | 02013576 | Tablet - Oral | 160 MG | 12/31/1994 |
MOISTUREL SENSITIVE SKIN LOTION | glaxosmithkline consumer healthcare ulc | 01909169 | Lotion - Topical | 3 % / W/W | 12/31/1991 |
CIMA AEMPS Drug Approvals
Approved Product | Company | Registration Number | Pharmaceutical Form | Prescription Type | Status |
---|---|---|---|---|---|
AEROFLAT 5 mg/ 77,5 mg COMPRIMIDOS MASTICABLES | 53610 | COMPRIMIDO MASTICABLE | Medicamento Sujeto A Prescripción Médica | Not Commercialized | |
PANKREOFLAT 172 MG/80 MG COMPRIMIDOS RECUBIERTOS | 44633 | COMPRIMIDO | Sin Receta | Commercialized |
Philippines FDA Drug Approvals
Approved Product | Company | License Number | Dosage Form | Strength | Approval Date |
---|---|---|---|---|---|
No Philippines FDA approvals found for this drug. |
Saudi SFDA Drug Approvals
Approved Product | Company | License Number | Dosage Form | Strength | Approval Date |
---|---|---|---|---|---|
No Saudi SFDA approvals found for this drug. |
Malaysia NPRA Drug Approvals
Approved Product | Company | Registration Number | Dosage Form | Strength | Approval Date |
---|---|---|---|---|---|
No Malaysia NPRA approvals found for this drug. |
UK EMC Drug Information
Medicine Name | MA Holder | MA Number | Pharmaceutical Form | Active Ingredient | Authorization Date |
---|---|---|---|---|---|
No UK EMC drug information found for this drug. |
Help Us Improve
Your feedback helps us provide better drug information and insights.